Grifols, S.A. (BME:GRF)
8.83
-0.12 (-1.36%)
Apr 28, 2026, 1:35 PM CET
Grifols Market Cap
Grifols has a market cap or net worth of €5.57 billion as of April 28, 2026. Its market cap has increased by 8.61% in one year.
Market Cap
5.57B
Enterprise Value
16.69B
Revenue
7.52B
Ranking
n/a
PE Ratio
15.17
Stock Price
€8.83
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 729.00M to 5.57B, an increase of 663.88%. That is a compound annual growth rate of 10.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 5.57B | -14.82% |
| Dec 31, 2025 | 6.54B | 15.08% |
| Dec 31, 2024 | 5.68B | -38.46% |
| Dec 29, 2023 | 9.23B | 40.77% |
| Dec 30, 2022 | 6.56B | -32.97% |
| Dec 30, 2021 | 9.78B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laboratorios Farmaceuticos Rovi | 4.15B |
| Almirall | 2.73B |
| Pharma Mar | 1.64B |
| Faes Farma | 1.49B |
| Clínica Baviera | 832.96M |
| Prim, S.A. | 225.43M |
| Atrys Health | 220.51M |
| Laboratorio Reig Jofre | 217.37M |